KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type NGS Genetic DNA Test
Introduction
The KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type NGS Genetic DNA Test is a specialized genetic test that plays a pivotal role in diagnosing epidermolysis bullosa simplex, particularly the Dowling-Meara type. This condition is characterized by fragile skin that blisters easily, causing significant discomfort and complications for affected individuals. Understanding the genetic basis of this disorder is essential for effective management and treatment.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to analyze the KRT14 gene, which is crucial for maintaining skin integrity. By detecting mutations in this gene, the test can confirm a diagnosis of epidermolysis bullosa simplex, providing valuable information for both patients and healthcare providers.
Who Should Consider This Test
Individuals with a family history of epidermolysis bullosa simplex or those exhibiting symptoms such as blistering skin, sensitivity, or chronic wounds should consider this test. It is particularly important for patients experiencing unexplained skin fragility or those with a genetic predisposition to this condition.
Benefits of Taking the Test
- Accurate diagnosis of epidermolysis bullosa simplex, allowing for tailored treatment plans.
- Early intervention to prevent complications associated with the disorder.
- Informed family planning decisions based on genetic insights.
- Access to specialized care and support from dermatologists and genetic counselors.
Understanding Your Results
Results from the KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type NGS Genetic DNA Test will be communicated clearly, with guidance provided on the implications of the findings. A positive result may indicate a higher risk for developing symptoms, while a negative result can provide reassurance.
Test Pricing
Price Type | Amount (NGN) |
---|---|
Discount Price | 400000 NGN |
Regular Price | 560000 NGN |
Book the Test
To ensure your health and gain insights into potential genetic risks, book the KRT14 Gene Epidermolysis Bullosa Simplex Dowling-Meara Type NGS Genetic DNA Test today. For more information or to schedule an appointment, please call or WhatsApp us at +2348077798758.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected by the KRT14 gene.
Consult with a dermatologist or a genetic specialist to discuss the relevance of this test to your health and family history.